Owners, management and financials
CVR: 29625867
Previous names: MATRIX PHARMACEUTICALS A/S
DKK 1,090,380
Revenue
Net result: DKK 589,123
Karsten Høilund Skafte (100%), KHS HOLDING ApS (100%)
CVR · view owners
Karsten Høilund Skafte
Board: 1 member
CVR · view management
Active
Founded 26 June 2006
CVR · view overview
1 employee
CVR · 2026
Name registered: MATRIX PHARMACEUTICALS ApS
CVR · 01/09/2020
View the full event history
MATRIX PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MATRIX PHARMACEUTICALS A/S. The management consists of Karsten Høilund Skafte. The board consists of Karsten Høilund Skafte. The company is owned by Karsten Høilund Skafte and KHS HOLDING ApS. The company has 1 employee (2026). In 2025, the company reported revenue of DKK 1,090,380 and a net result of DKK 589,123 compared with DKK 440,028 the year before. Equity in the 2025 report amounted to DKK 589,123.
Source: annual report 2025, Danish Business Authority
MATRIX PHARMACEUTICALS ApS has shown a positive trajectory in financial health, with revenue increasing from 980,760 DKK in 2024 to 1,090,380 DKK in 2025, alongside a notable rise in profit from 440,028 DKK to 589,123 DKK. The company's gross profit margins appear strong, reflecting effective cost management, although equity has fluctuated significantly, moving from negative to positive territory, indicating improved financial stability. Despite previous years of negative equity, the current position suggests a recovery, with equity reaching 589,123 DKK in 2025. As a player in the wholesale trade of pharmaceuticals and medical supplies, MATRIX PHARMACEUTICALS is well-positioned within its industry, although ongoing attention to equity and potential debt levels will be crucial for sustained growth.
AI-generated summary · Generated 20/08/2026
Selskabets formål er at importere/eksportere, sælge, markedsføre og distribuere lægemidler.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.1 mio. | 589 t. | 589 t. | 589 t. | 1 | |
| 202401/01/2024 – 31/12/2024 | 981 t. | 440 t. | 269 t. | 60 t. | 1 | |
| 202301/01/2023 – 31/12/2023 | 1.2 mio. | 544 t. | 91 t. | -44 t. | - | |
| 202201/01/2022 – 31/12/2022 | 1.2 mio. | 580 t. | 96 t. | -80 t. | - | |
| 202101/01/2021 – 31/12/2021 | - | 776 t. | 120 t. | -678 t. | 1 | |
| 202001/01/2020 – 31/12/2020 | - | 731 t. | 96 t. | -1.5 mio. | 1 | |
| 201901/01/2019 – 31/12/2019 | - | -310 t. | 167 t. | -2.2 mio. | - | |
| 201801/01/2018 – 31/12/2018 | -56 t. EUR | -638 t. EUR | 1.9 mio. EUR | -1.9 mio. EUR | - | |
| 201701/01/2017 – 31/12/2017 | - | -369 t. | 2.2 mio. | -1.2 mio. | - | |
| 201601/01/2016 – 31/12/2016 | - | -338 t. | 3 mio. | 459 t. | - | |
| 201501/01/2015 – 31/12/2015 | - | 211 t. | 2.9 mio. | 797 t. | - | |
| 201401/01/2014 – 31/12/2014 | - | 754 t. | 4.5 mio. | 587 t. | - | |
| 201301/01/2013 – 31/12/2013 | 8.6 mio. | 961 t. | 3.1 mio. | -167 t. | - | |
| 201201/01/2012 – 31/12/2012 | 4.5 mio. | 79 t. | 1.3 mio. | -1.1 mio. | - |
Compared to 405 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of MATRIX PHARMACEUTICALS ApS is 29625867.
MATRIX PHARMACEUTICALS ApS is owned by Karsten Høilund Skafte and KHS HOLDING ApS.
The management of MATRIX PHARMACEUTICALS ApS consists of Karsten Høilund Skafte.
The board of MATRIX PHARMACEUTICALS ApS consists of Karsten Høilund Skafte.
In 2025, MATRIX PHARMACEUTICALS ApS reported revenue of DKK 1,090,380.
MATRIX PHARMACEUTICALS ApS had 1 employee in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2025. Revenue came to DKK 1,090,380, and the net result was DKK 589,123.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2024. Revenue came to DKK 980,760, and the net result was DKK 440,028.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2023. Revenue came to DKK 1,193,100, and the net result was DKK 544,125.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2022. Revenue came to DKK 1,166,040, and the net result was DKK 580,419.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2021. Gross profit came to DKK 842,995, and the net result was DKK 776,310.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2020. Gross profit came to DKK 849,186, and the net result was DKK 730,861.
As of November 1, 2020, Steen Larsen has left the board of directors of MATRIX PHARMACEUTICALS ApS.
As of November 1, 2020, Anders Leif Håkansson has left the board of directors of MATRIX PHARMACEUTICALS ApS.
On September 1, 2020, the company changed its name from MATRIX PHARMACEUTICALS A/S to MATRIX PHARMACEUTICALS ApS.
As of September 1, 2020, Karsten Høilund Skafte is registered as an owner of MATRIX PHARMACEUTICALS ApS with an ownership share of 100%.
As of September 1, 2020, KHS HOLDING ApS is registered as an owner of MATRIX PHARMACEUTICALS ApS with an ownership share of 100%.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2019. Gross profit came to DKK 35,458, and the net result was DKK -310,051.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2018. Revenue came to DKK -55,731, and the net result was DKK -637,810.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK 266,980, and the net result was DKK -368,860.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2016. Gross profit came to DKK -39,517, and the net result was DKK -337,843.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2015. Gross profit came to DKK 449,556, and the net result was DKK 210,538.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2014. Gross profit came to DKK 928,617, and the net result was DKK 753,731.
As of May 27, 2015, BHA STATSAUTORISERET REVISION APS has been appointed auditor of MATRIX PHARMACEUTICALS ApS.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2013. Revenue came to DKK 8,648,304, and the net result was DKK 961,193.
As of May 31, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of MATRIX PHARMACEUTICALS ApS.
As of January 21, 2014, Steen Larsen has joined the board of directors of MATRIX PHARMACEUTICALS ApS.
As of January 21, 2014, Mariann Florin Skafte has left the board of directors of MATRIX PHARMACEUTICALS ApS.
MATRIX PHARMACEUTICALS ApS has published its annual report for 2012. Revenue came to DKK 4,460,599, and the net result was DKK 78,904.
As of May 15, 2013, Anders Leif Håkansson has joined the board of directors of MATRIX PHARMACEUTICALS ApS.
As of May 15, 2013, Peter Lassen has left the board of directors of MATRIX PHARMACEUTICALS ApS.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MATRIX PHARMACEUTICALS ApS.
As of July 1, 2011, has stepped down as auditor of MATRIX PHARMACEUTICALS ApS.
As of February 28, 2010, Peter Lassen has joined the board of directors of MATRIX PHARMACEUTICALS ApS.
As of February 28, 2010, Christoph Kerstein has left the board of directors of MATRIX PHARMACEUTICALS ApS.
As of May 25, 2009, Christoph Kerstein has joined the board of directors of MATRIX PHARMACEUTICALS ApS.
As of May 25, 2009, Stefan Gliwitzki-Grabner has left the board of directors of MATRIX PHARMACEUTICALS ApS.
As of June 26, 2006, has been appointed auditor of MATRIX PHARMACEUTICALS ApS.
As of June 26, 2006, Mariann Florin Skafte has joined the board of directors of MATRIX PHARMACEUTICALS ApS.
As of June 26, 2006, Karsten Høilund Skafte has joined the board of directors of MATRIX PHARMACEUTICALS ApS.
As of June 26, 2006, Stefan Gliwitzki-Grabner has joined the board of directors of MATRIX PHARMACEUTICALS ApS.
As of June 26, 2006, Karsten Høilund Skafte is registered as director of MATRIX PHARMACEUTICALS ApS.
MATRIX PHARMACEUTICALS ApS was founded on June 26, 2006.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 46788176
CVR 45929698
CVR 46098765
CVR 46098773
CVR 19064301
